pharmacovigilance

Pharmacovigilance 2011 will discuss the pressing concerns confronted with regard to drug safety, addressing the risks, time line, budget constrains, effectively tackling key challenges, overcoming trial agreement and site contract negotiation hurdles. The Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. The entire program will cover the detection, analysis and prevention of adverse drug reactions. It will be studied with the help of case studies and industry experiences. Hence, 2nd Annual Pharmacovigilance 2011 will provide an important platform for Pharmacovigilance stakeholders from India to discuss and share best practices in expediting Pharmacovigilance development in India.

Online PR News – 15-July-2011 – – 2nd Annual Pharmacovigilance 2011

“Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management”

August 19th 2011, ITC Maratha Hotel, Sahar, Mumbai, India.

For more info on the event and for event brochure kindly visit –
http://virtueinsight.com/site/Pharma_Details.aspx?SC_ID=9

Key Themes Discussed at this Summit:

• Exploiting the latest technologies and methodologies on work practices of Pharmacovigilance
• Keeping abreast of the changes impacting the drug safety industry to ensure the pharmacovigilance strategies are robust and geared to compliance
• Learn to implement best practices in drug safety and surveillance
• Recent successful strategies and business models to manufacture new medicine
• Global marketing strategies in order to engage with regulatory centers of excellence on pharmacovigilance
• Introducing newer medicines with limited real-world safety data
• Accelerating new medicine introduction in developing world & overcoming challenges
• Recognizing the most effective pharmacovigilance system
• Future studies of pharmacovigilance activity levels globally
• Discuss and share best practices in expediting PV development in India
• Stay ahead of computing and electronic communications in pharmacovigilance
• Analyzing the information on current industry projects and trends
• Good supply chain management practices for medicine distribution
• Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
• Latest developments in pharmacovigilance, drug safety and risk management to ensure safer drugs to market
• Be part of a major networking opportunity

Key Speakers Include:

• Arun Bhatt, President, Clininvent Research
• Vivek Ahuja, Regional Director, Pharmacovigilance, Baxter Healthcare, Asia Pacific
• Khalid Saifuddin, Group Head Pharmacovigilance Operations - Drug Safety & Epidemiology, Novartis
• Moin Don, Executive Director, PVCON Pharmacovigilance Consulting Services
• Babita Kirodian, Head-Country Pharmacovigilance, Bristol Myers Squibb
• Parminder Kaur, Managing Director, RegPak BioPharma Consulting (Netherlands)
• Deven Parmar, Vice President-Clinical Research, Wockhardt
• Julius Vaz, Senior Vice-President (Global Medical Affairs), Dr.Reddy's
• Deepti Sanghavi, Medical Advisor- Clinical Research, Wockhardt
• Rajani Rokade, Head – Pharmacovigilance, Sanofi Aventis Group
• Manish R Garg , Country Medical Director, Bayer
• Simrat Sohal,Clinical Research Physician - Patient safety , Critical Care, Cardiac Care & BHGT, Eli Lilly
• Milind Antani, Head-Pharma LifeSciences group, Nishith Desai Associates
• Anurita Majumdar, Medical Director, Eli Lilly
• Ramaswamy Valliappan, Pharmacovigilance Expert (PVE) - Integrated Hospital Care Drug Safety and Epidemiology, Novartis

Plus many more.....

Who Should Attend:

VP’s, Directors, CRO’s, Heads and Managers of:

• Pharmacovigilance Strategy
• Drug Safety/Risk Management
• Information and Clinical Data Management
• Clinical Research
• Research & Development
• Product Safety/Assurance Assessment
• Patient Safety & Outcomes Research & Data Analysis
• Epidemiology project management
• Regulatory Affairs and Compliance
• Sales & Marketing
• Biotechmanufacturers

Why Should You Attend:

2nd Annual Pharmacovigilance 2011- “ Ensuring safer drugs to market by analysing latest developments in PV, drug safety and risk management ”

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

Ordering Delegate Place –
Register now as delegate, sponsor and exhibitor

Conference Delegate Pass (INR 5,000 + Tax per delegate) - You can simply email or call and book your conference delegate seats on TEL: +91 (44) 65515695. Email – jag@virtueinsight.com
Conference Sponsor -Speaker & Exhibition Stall - Should you wish to Sponsor and Speak at our conference, or purchase an Exhibition Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to – jag@virtueinsight.com

Bookmarkse-mailGoogledel.icio.usStumbleUponSlashdotFurlDiggTechnoratiYahooMyWebBlinkListSpurlRawSugarWists
 
 
Contact Information
jag
Virtue Insight
40, Alwarthirunagar
Chennai tamilnadu, 600087

+91 (44) 65515695